Minneapolis Veterans Affairs Medical Center
va.govTotal trials
40
Active
4
Phase 3
6
Total enrollment
6,910
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 4 of 4 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| IV ketamine | — | — | — | — | — | 1 | |
| Midazolam | — | — | — | — | — | 1 | |
| Active tDCS and Cognitive Training Intervention | — | — | — | — | — | 1 | |
| Sham tDCS and Cognitive Training Intervention | — | — | — | — | — | 1 |
Next readouts
- 2026-12
- 2027-09
Top conditions
- Traumatic Brain Injury4
- Chronic Pain3
- Type 2 Diabetes3
- Alcoholism2
- Impulsivity2
- Diabetes Mellitus2
- Osteoarthritis, Knee2
- Arthritis2
Frequently asked questions about Minneapolis Veterans Affairs Medical Center
- How many clinical trials does Minneapolis Veterans Affairs Medical Center have on ClinicalTrials.gov?
- Minneapolis Veterans Affairs Medical Center is listed as the lead sponsor on 40 clinical trials in ClinicalTrials.gov, 4 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Minneapolis Veterans Affairs Medical Center's trials are in Phase 3?
- 6 of Minneapolis Veterans Affairs Medical Center's trials are in Phase 3, spread across 4 active drug programs.
- What therapeutic areas does Minneapolis Veterans Affairs Medical Center focus on?
- Minneapolis Veterans Affairs Medical Center's most-studied conditions on ClinicalTrials.gov are Traumatic Brain Injury, Chronic Pain, Type 2 Diabetes, Alcoholism, Impulsivity.
- When are Minneapolis Veterans Affairs Medical Center's next clinical trial readouts?
- Minneapolis Veterans Affairs Medical Center has 2 upcoming primary-completion readouts tracked here; the soonest is “Ketamine Treatment for PTSD and MDD in TBI”, expected around 2026-12.